TIDMBYOT

RNS Number : 6098K

Byotrol PLC

22 September 2016

22 September 2016

Byotrol plc

("Byotrol" or the "Company")

Result of AGM

Byotrol plc, the developer of anti-microbial technologies, confirms that at its Annual General Meeting held earlier today, all resolutions were duly passed.

A copy of the presentation used at the AGM is available on the Company's website www.byotrol.co.uk.

Enquiries:

 
 Byotrol plc                        01925 742 000 
 David Traynor - Chief Executive 
 
 finnCap Ltd                        020 7220 0500 
 (Nominated Adviser & Broker) 
 Geoff Nash/Carl Holmes/James 
  Thompson - Corporate Finance 
 Mia Gardner - Corporate Broking 
 
 

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial technologies.

Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.

For more information, please go to www.byotrol.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGLLFSEAAIFFIR

(END) Dow Jones Newswires

September 22, 2016 11:51 ET (15:51 GMT)

Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Byotrol Charts.
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Byotrol Charts.